Published in Thorax on November 01, 2013
Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium. BMC Fam Pract (2015) 1.39
Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project). BMC Infect Dis (2016) 1.37
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis (2014) 1.22
Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study. BMC Infect Dis (2016) 1.09
Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012. Emerg Infect Dis (2015) 1.08
Alcoholism: a systemic proinflammatory condition. World J Gastroenterol (2014) 0.96
Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? Eur J Clin Microbiol Infect Dis (2014) 0.93
Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study. Medicine (Baltimore) (2015) 0.86
Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases. Korean J Intern Med (2014) 0.84
The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir Med (2014) 0.83
Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults. Hum Vaccin Immunother (2014) 0.81
A Bayesian Approach to Identifying New Risk Factors for Dementia: A Nationwide Population-Based Study. Medicine (Baltimore) (2016) 0.80
Fatty acid-binding proteins as biomarkers of disease severity and outcome in community-acquired pneumonia. Ann Transl Med (2016) 0.80
A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults. BMC Pulm Med (2016) 0.80
Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination. Int J Mol Sci (2016) 0.77
Risk factors for infectious readmissions following radical cystectomy: results from a prospective multicenter dataset. Ther Adv Urol (2016) 0.77
Vitamin D status and acute respiratory infection: cross sectional results from the United States National Health and Nutrition Examination Survey, 2001-2006. Nutrients (2015) 0.77
Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness. J Prev Med Hyg (2015) 0.76
Passive smoking at home is a risk factor for community-acquired pneumonia in older adults: a population-based case-control study. BMJ Open (2014) 0.76
Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells. Am J Physiol Lung Cell Mol Physiol (2016) 0.76
A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers. Clin Drug Investig (2015) 0.76
Rate of aspiration pneumonia in hospitalized Parkinson's disease patients: a cross-sectional study. BMC Neurol (2015) 0.76
Recurrent pneumonia among Japanese adults: disease burden and risk factors. BMC Pulm Med (2017) 0.75
The Impacts of Cellular Senescence in Elderly Pneumonia and in Age-Related Lung Diseases That Increase the Risk of Respiratory Infections. Int J Mol Sci (2017) 0.75
Epidemiology, virulence factors and management of the pneumococcus. F1000Res (2016) 0.75
Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during two influenza seasons. Hum Vaccin Immunother (2016) 0.75
Are third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective study. Ann Intensive Care (2017) 0.75
Relationship between Plasma Levels of Zinc and Clinical Course of Pneumonia. Tanaffos (2017) 0.75
Health care and social care costs of pneumonia in Denmark: a register-based study of all citizens and patients with COPD in three municipalities. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Impact of an Educational Program to Reduce Healthcare Resources in Community-Acquired Pneumonia: The EDUCAP Randomized Controlled Trial. PLoS One (2015) 0.75
The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study. BMC Geriatr (2016) 0.75
Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease. CMAJ (2017) 0.75
Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Fatty acid binding proteins as biomarkers of disease severity and response to treatment in severe pneumonia required admission to intensive care unit. Ann Transl Med (2016) 0.75
Risk of pneumonia and urinary tract infection within the first week after total hip arthroplasty and the impact on survival. Clin Epidemiol (2017) 0.75
Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study. Hum Vaccin Immunother (2015) 0.75
Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections. EBioMedicine (2017) 0.75
Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study. Neuropsychiatr Dis Treat (2016) 0.75
An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital. BMC Infect Dis (2016) 0.75
Traditional Chinese medicine therapy decreases the pneumonia risk in patients with dementia. Medicine (Baltimore) (2016) 0.75
Lung ultrasound and chest x-ray for detecting pneumonia in an acute geriatric ward. Medicine (Baltimore) (2016) 0.75
Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines. Int J Mol Sci (2016) 0.75
Evidence summary: the relationship between oral health and pulmonary disease. Br Dent J (2017) 0.75
Fatty acid-binding proteins as diagnostic and prognostic markers in pneumonia. Ann Transl Med (2016) 0.75
Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study. Br J Clin Pharmacol (2017) 0.75
Reliability of a laryngo-pharyngeal esthesiometer and a method for measuring laryngo-pharyngeal mechano-sensitivity in a prospectively recruited cohort of patients. Eur Arch Otorhinolaryngol (2017) 0.75
Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine. Eur J Clin Microbiol Infect Dis (2016) 0.75
Prediction of pneumonia hospitalization in adults using health checkup data. PLoS One (2017) 0.75
Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study. Infection (2017) 0.75
Increased risk of pneumonia in residents living near poultry farms: does the upper respiratory tract microbiota play a role? Pneumonia (Nathan) (2017) 0.75
The Prevalence of Oropharyngeal Dysphagia in Danish Patients Hospitalised with Community-Acquired Pneumonia. Dysphagia (2016) 0.75
Pneumococcal vaccination in autoimmune rheumatic diseases. RMD Open (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) (2003) 34.28
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health (1992) 15.38
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ (2009) 4.38
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec (2012) 3.63
Guidelines for the management of adult lower respiratory tract infections. Eur Respir J (2005) 3.51
Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax (2010) 3.34
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax (2009) 3.21
Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (2008) 3.13
Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med (2008) 3.10
Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med (2007) 2.85
Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med (2007) 2.69
Pneumococcal vaccines WHO position paper--2012. Wkly Epidemiol Rec (2012) 2.51
Determinants of community-acquired pneumonia in children and young adults in primary care. Eur Respir J (2010) 2.28
Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J (2010) 2.20
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax (2012) 2.17
A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med (2000) 2.14
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10
Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis (2004) 2.06
Alcohol, host defence and society. Nat Rev Immunol (2002) 2.05
Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99
Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care (2008) 1.97
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97
23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec (2008) 1.92
Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med (2010) 1.91
Risk factors for pneumonia in the elderly. Am J Med (1994) 1.89
New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J (2008) 1.70
Recommended adult immunization schedule: United States, 2009*. Ann Intern Med (2009) 1.69
Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing (2009) 1.67
Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy (2007) 1.61
Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax (2006) 1.60
Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J (2006) 1.58
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med (2008) 1.57
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J (2006) 1.56
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J (2009) 1.54
Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest (2006) 1.50
The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect (2006) 1.45
Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract (2009) 1.40
Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf (2009) 1.37
Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients (2012) 1.33
Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med (2008) 1.32
Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract (2007) 1.32
Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest (1999) 1.30
The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med (2012) 1.26
Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect (2012) 1.24
Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect (2009) 1.16
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med (2008) 1.15
Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis (2008) 1.14
Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax (1994) 1.13
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J (2011) 1.11
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect (2012) 1.09
Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care (2011) 1.09
Acid-suppressive drugs and community-acquired pneumonia. Epidemiology (2009) 1.06
Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respir Med (2005) 1.06
Community-acquired pneumonia. Minerva Anestesiol (2011) 1.06
Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect (2009) 1.05
A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med (2007) 1.02
Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 1.02
The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study. Crit Care (2012) 0.99
Alcohol drinking and risk of subsequent hospitalisation with pneumonia. Eur Respir J (2011) 0.96
Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect (2005) 0.96
Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis (1995) 0.96
Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) (2011) 0.94
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen. HIV Med (2006) 0.94
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection (2008) 0.94
Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. PLoS One (2010) 0.93
Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect (2007) 0.92
Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J (2012) 0.91
Community-acquired pneumonia in younger patients is an entity on its own. Eur Respir J (2011) 0.91
Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect (2011) 0.91
Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Med Clin (Barc) (2011) 0.91
Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med (2008) 0.90
Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J (2011) 0.90
Risk of pneumonia in patients taking statins: population-based nested case-control study. Br J Gen Pract (2011) 0.90
Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology (2009) 0.90
A survey on hospitalised community-acquired pneumonia in Italy. Monaldi Arch Chest Dis (2006) 0.88
Lower respiratory tract infections caused by Haemophilus influenzae: clinical features and predictors of outcome. Med Sci Monit (2009) 0.87
Community-acquired legionella pneumonia in elderly patients: characteristics and outcome. J Am Geriatr Soc (2007) 0.87
Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens (2007) 0.86
Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay. Infection (2010) 0.85
Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol (2007) 0.85
Inhaled drugs as risk factors for community-acquired pneumonia. Eur Respir J (2010) 0.85
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. Infection (2009) 0.83
Sporadic community-acquired Legionnaires' disease in France: a 2-year national matched case-control study. Epidemiol Infect (2008) 0.81
Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods. HIV Med (2008) 0.79
Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases? Expert Rev Respir Med (2009) 0.78
The effect of telithromycin in acute exacerbations of asthma. N Engl J Med (2006) 5.35
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis (2012) 4.62
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med (2003) 3.94
Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med (2004) 3.42
Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc (2008) 2.78
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia. Eur Respir J (2013) 2.69
Heated Humidified High-Flow Nasal Oxygen in Adults: Mechanisms of Action and Clinical Implications. Chest (2015) 2.66
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest (2009) 2.34
Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med (2006) 2.28
The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev (2003) 2.22
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J (2013) 2.20
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest (2013) 2.19
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med (2012) 2.14
A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 2.08
The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis (2011) 1.97
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood (2004) 1.83
Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS (2004) 1.75
Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia. Mayo Clin Proc (2007) 1.71
uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol (2004) 1.71
Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS (2008) 1.54
Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med (2014) 1.53
Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J (2003) 1.52
Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med (2004) 1.50
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis (2008) 1.49
Bronchiectasis: an update. Clin Respir J (2009) 1.48
Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med (2013) 1.48
Outcome of patients requiring valve surgery during active infective endocarditis. Ann Thorac Surg (2008) 1.47
Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections. Pediatr Infect Dis J (2005) 1.47
Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol (2006) 1.46
Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index. Eur Respir J (2013) 1.45
Tuberculosis elimination: theory and practice in Europe. Eur Respir J (2014) 1.42
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax (2013) 1.41
ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes. Crit Care Med (2013) 1.41
Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J (2006) 1.40
Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem (2005) 1.33
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs (2007) 1.30
Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol (2007) 1.30
Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med (2014) 1.29
Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J (2007) 1.29
A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny. Development (2005) 1.25
Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J Biol Chem (2002) 1.25
The urokinase receptor as an entertainer of signal transduction. Front Biosci (Landmark Ed) (2009) 1.21
Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. Cell Rep (2013) 1.21
Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. J Clin Invest (2009) 1.19
Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J Biol Chem (2003) 1.19
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis (2009) 1.18
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother (2004) 1.17
Expression of Hoxa2 in rhombomere 4 is regulated by a conserved cross-regulatory mechanism dependent upon Hoxb1. Dev Biol (2006) 1.17
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol Cell Biol (2005) 1.17
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest (2004) 1.17
MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood (2004) 1.15
An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol Biol Cell (2005) 1.15
Hoxb1 enhancer and control of rhombomere 4 expression: complex interplay between PREP1-PBX1-HOXB1 binding sites. Mol Cell Biol (2005) 1.14
Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults. PLoS Negl Trop Dis (2012) 1.14
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci (2004) 1.14
Prep1.1 has essential genetic functions in hindbrain development and cranial neural crest cell differentiation. Development (2004) 1.12
Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns. PLoS One (2013) 1.12
Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994-2002. Pediatrics (2006) 1.11
Clinical and echocardiographic risk factors for embolism and mortality in infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.11
(18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging (2010) 1.08
Bloodstream infections in south and southeast Asia. Lancet Infect Dis (2013) 1.08
Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia. J Cereb Blood Flow Metab (2012) 1.08
Management of prosthetic valve infective endocarditis. Am J Cardiol (2008) 1.08
Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother (2010) 1.07
Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev Dyn (2013) 1.07
Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol Cell Biol (2008) 1.07
Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. PLoS One (2008) 1.06
Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol Cell Proteomics (2009) 1.05
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity. Dev Biol (2007) 1.05
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis (2012) 1.05
p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity. Mol Cell Biol (2007) 1.04
A cross-sectional study assessing the relationship between BMI, asthma, atopy, and eNO among schoolchildren. Ann Allergy Asthma Immunol (2011) 1.03
Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling. Mol Pharm (2013) 1.03
Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med (2006) 1.03
Induction of HoxB transcription by retinoic acid requires actin polymerization. Mol Biol Cell (2009) 1.03
Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke. PLoS One (2013) 1.02
Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. Thromb Haemost (2002) 1.01
Geographical information system and environmental epidemiology: a cross-sectional spatial analysis of the effects of traffic-related air pollution on population respiratory health. Environ Health (2011) 1.01
The ARGA study with general practitioners: impact of medical education on asthma/rhinitis management. Respir Med (2012) 1.01
Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels. Mol Cell Biol (2008) 1.01
The role of sigmaB in persistence of Staphylococcus epidermidis foreign body infection. Microbiology (2008) 1.01
Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res (2013) 1.00
Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis (2002) 1.00
Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol (2002) 1.00
Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation. PLoS One (2009) 0.99
The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant (2004) 0.99
Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. J Antimicrob Chemother (2010) 0.99
Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. J Bone Miner Res (2007) 0.99
Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis (2002) 0.97
Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. Chest (2009) 0.96
Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proc Natl Acad Sci U S A (2014) 0.96
Respiratory health and indoor air pollutants based on quantitative exposure assessments. Eur Respir J (2012) 0.96
Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol (2004) 0.95
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro. J Cell Sci (2008) 0.95
Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. Proc Natl Acad Sci U S A (2011) 0.95
Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era. J Antimicrob Chemother (2007) 0.95